Sotera Health Co (SHC) stock
Close on Nov 13, 2026Market cap $4.74BP/E 29.1Yield –
Sotera Health Co grew revenue 8.1% to $1.22B over the twelve months to Jun 30, 2026. Free cash flow was $112.70M, up 0.0% from a year earlier. At the latest close the market valued the company at $4.74B, 29.1 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.74B
- P/E ratio
- 29.1
- Price to sales
- 3.90
- Price to book
- 7.12
- Dividend yield
- –
- Free cash flow yield
- 2.38%
Fundamentals
- Revenue
- $1.22B
- Net income
- $163.48M
- EPS, diluted
- $0.57
- Free cash flow
- $112.70M
- Book value per share
- $2.31
- Diluted shares
- 288M
Trading
- Next earnings
- Feb 23, 2027 (estimated, before the open)
- Previous close
- $16.30
- Open
- $16.39
- Day's range
- $16.15 – $16.65
- Volume
- 2,647,531
- Average volume (20 days)
- 2,700,133
- Index membership
- S&P MidCap 400 (since Aug 2022), Russell 1000 (since Mar 2021), Russell 3000 (since Nov 2020)
- Beta (5 years)
- 1.59
- 52-week range
- $13.09 – $19.85
- RSI (14 days)
- 41.6
- Volatility (1 year)
- 30.3%
- Relative volume
- 1.06×
- WACC
- 10.4%
Index membership is inferred from the holdings of funds that track each index (IJH, SPMD, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | SHC | S&P 500 | Difference | SHC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -8.8% | -3.0% | −5.7 pts | ||
| 3 months | -12.7% | -2.8% | −9.9 pts | ||
| Year to date | -5.8% | +11.5% | −17.3 pts | ||
| 1 year | +3.7% | +13.5% | −9.7 pts | ||
| 3 years | +27.1% | +77.7% | −50.6 pts | +8.3% | +21.1% |
| 5 years | -28.0% | +72.6% | −100.6 pts | -6.4% | +11.5% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Sotera Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Sotera Health
Services-Misc Health & Allied Services, NEC
The company provides outsourced terminal sterilization solutions, microbiological and analytical lab testing, and technical advisory services. It operates primarily through two segments: Sterilization Services (comprising Sterigenics and Nordion) and Lab Testing and Advisory Services (Nelson Labs). Sterigenics delivers terminal sterilization using gamma irradiation, ethylene oxide processing, and electron-beam irradiation. Nordion supplies Cobalt-60 radiation sources and manufactures gamma irradiation units for industrial sterilization and oncology applications. Nelson Labs conducts testing across healthcare product life cycles, including sterility assurance, biocompatibility, and regulatory compliance consulting. The company primarily serves medical device and pharmaceutical manufacturers, alongside food safety and advanced commercial customers.
Company profile, executives and historySotera Health stock: common questions
What is Sotera Health's stock price?
SHC closed at $16.61 on Nov 13, 2026, up 1.90% on the day. Over the past 52 weeks it traded between $13.09 and $19.85.
What is Sotera Health's market cap?
Sotera Health was worth $4.74B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is SHC's P/E ratio?
SHC trades at 29.1 times earnings, based on diluted earnings per share of $0.57 over the twelve months to Jun 30, 2026.
How much revenue does Sotera Health make?
Sotera Health reported revenue of $1.22B for the twelve months to Jun 30, 2026, up 8.1% from a year earlier.
Does Sotera Health pay a dividend?
No. Sotera Health has not paid a cash dividend over the last twelve months.
When does Sotera Health report earnings next?
Sotera Health is expected to report Q4 FY2026 results on Feb 23, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has SHC stock performed over the past year?
Including dividends, SHC returned +3.7% over the past year, against +13.5% for the S&P 500.
Who are Sotera Health's competitors?
Companies most similar to Sotera Health by business, industry and size include PGNY, CON, VMD, AGL, FTRE.
See a number that looks wrong?